Skip to main content
Capricor Therapeutics, Inc. (CAPR)
NASDAQ: CAPR · Real-Time Price · USD
18.92
+0.46 (2.49%)
At close: Nov 20, 2024, 4:00 PM
18.54
-0.38 (-2.01%)
Pre-market: Nov 21, 2024, 6:07 AM EST

Capricor Therapeutics Revenue

Capricor Therapeutics had revenue of $2.26M in the quarter ending September 30, 2024, a decrease of -63.44%. This brings the company's revenue in the last twelve months to $23.23M, up 65.33% year-over-year. In the year 2023, Capricor Therapeutics had annual revenue of $25.18M with 886.81% growth.

Revenue (ttm)
$23.23M
Revenue Growth
+65.33%
P/S Ratio
25.86
Revenue / Employee
$227,726
Employees
102
Market Cap
860.29M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202325.18M22.63M886.81%
Dec 31, 20222.55M2.31M941.85%
Dec 31, 2021244.90K-65.35K-21.06%
Dec 31, 2020310.25K-694.78K-69.13%
Dec 31, 20191.01M-666.33K-39.87%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Healthcare Services Group 1.70B
Embecta 1.12B
Paragon 28 245.00M
CeriBell 60.04M
Liquidia 15.61M
Relay Therapeutics 10.01M
Revenue Rankings

CAPR News

More News